[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100595891":3},{"organization":4,"armGroups":7,"interventions":28,"overallOfficials":34,"centralContacts":42,"locations":48,"responsibleParty":248,"collaborators":34,"id":250,"slug":251,"hasResults":252,"nctId":253,"briefTitle":254,"officialTitle":255,"acronym":34,"eligibilityCriteria":256,"healthyVolunteers":252,"sex":257,"minAge":258,"maxAge":259,"enrollmentInfo":260,"targetDuration":34,"studyType":263,"phases":264,"briefSummary":267,"conditions":268,"keywords":277,"overallStatus":51,"whyStopped":34,"lastUpdateSubmitDate":289,"lastUpdatePostDateStruct":290,"startDateStruct":293,"completionDateStruct":295,"leadSponsor":297,"locationsCount":298},{"fullName":5,"class":6},"Avenzo Therapeutics, Inc.","INDUSTRY",[8,14,20,24],{"label":9,"type":10,"description":11,"interventionNames":12},"Phase 1, monotherapy","EXPERIMENTAL","Group A",[13],"Drug: AVZO-1418",{"label":15,"type":10,"description":16,"interventionNames":17},"Phase 1, combination","Group B",[13,18,19],"Drug: Combination Agent 1","Drug: Combination Agent 2",{"label":21,"type":10,"description":22,"interventionNames":23},"Phase 2, monotherapy","Part A",[13],{"label":25,"type":10,"description":26,"interventionNames":27},"Phase 2, combination","Part B",[13,18,19],[29,35,39],{"type":30,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"DRUG","AVZO-1418","Specific dose in protocol specified schedule",[15,9,25,21],null,{"type":30,"name":36,"description":37,"armGroupLabels":38,"otherNames":34},"Combination Agent 1","Per label based on combination agent used",[15,25],{"type":30,"name":40,"description":37,"armGroupLabels":41,"otherNames":34},"Combination Agent 2",[15,25],[43],{"name":44,"role":45,"phone":46,"phoneExt":34,"email":47},"Medical Information","CONTACT","(858) 239-2944","ClinicalTrials@avenzotx.com",[49,66,77,88,99,110,121,131,141,152,163,173,184,195,205,215,226,237],{"facility":50,"status":51,"city":52,"state":53,"zip":54,"country":55,"countryCode":56,"cosmosGeoPoint":57,"geoPoint":62,"contacts":63},"Avenzo Therapeutics Recruiting Site","RECRUITING","Gilbert","Arizona","85234","United States","US",{"type":58,"coordinates":59},"Point",[60,61],-111.78903,33.35283,{"lat":61,"lon":60},[64],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},"Avenzo Therapeutics",{"facility":50,"status":51,"city":67,"state":68,"zip":69,"country":55,"countryCode":56,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Los Angeles","California","90048",{"type":58,"coordinates":71},[72,73],-118.24368,34.05223,{"lat":73,"lon":72},[76],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":78,"state":79,"zip":80,"country":55,"countryCode":56,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Denver","Colorado","80218",{"type":58,"coordinates":82},[83,84],-104.9847,39.73915,{"lat":84,"lon":83},[87],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":89,"state":90,"zip":91,"country":55,"countryCode":56,"cosmosGeoPoint":92,"geoPoint":96,"contacts":97},"New Haven","Connecticut","06510",{"type":58,"coordinates":93},[94,95],-72.92816,41.30815,{"lat":95,"lon":94},[98],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":100,"state":101,"zip":102,"country":55,"countryCode":56,"cosmosGeoPoint":103,"geoPoint":107,"contacts":108},"Washington D.C.","District of Columbia","20007",{"type":58,"coordinates":104},[105,106],-77.03637,38.89511,{"lat":106,"lon":105},[109],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":111,"state":112,"zip":113,"country":55,"countryCode":56,"cosmosGeoPoint":114,"geoPoint":118,"contacts":119},"Orlando","Florida","32827",{"type":58,"coordinates":115},[116,117],-81.37924,28.53834,{"lat":117,"lon":116},[120],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":122,"state":112,"zip":123,"country":55,"countryCode":56,"cosmosGeoPoint":124,"geoPoint":128,"contacts":129},"Sarasota","34232",{"type":58,"coordinates":125},[126,127],-82.53065,27.33643,{"lat":127,"lon":126},[130],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":132,"state":112,"zip":133,"country":55,"countryCode":56,"cosmosGeoPoint":134,"geoPoint":138,"contacts":139},"Tampa","33612",{"type":58,"coordinates":135},[136,137],-82.45843,27.94752,{"lat":137,"lon":136},[140],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":142,"state":143,"zip":144,"country":55,"countryCode":56,"cosmosGeoPoint":145,"geoPoint":149,"contacts":150},"Atlanta","Georgia","30322",{"type":58,"coordinates":146},[147,148],-84.38798,33.749,{"lat":148,"lon":147},[151],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":153,"state":154,"zip":155,"country":55,"countryCode":56,"cosmosGeoPoint":156,"geoPoint":160,"contacts":161},"Boston","Massachusetts","02215",{"type":58,"coordinates":157},[158,159],-71.05977,42.35843,{"lat":159,"lon":158},[162],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":164,"state":164,"zip":165,"country":55,"countryCode":56,"cosmosGeoPoint":166,"geoPoint":170,"contacts":171},"New York","10029",{"type":58,"coordinates":167},[168,169],-74.00597,40.71427,{"lat":169,"lon":168},[172],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":174,"state":175,"zip":176,"country":55,"countryCode":56,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"Philadelphia","Pennsylvania","19107",{"type":58,"coordinates":178},[179,180],-75.16362,39.95238,{"lat":180,"lon":179},[183],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":185,"state":186,"zip":187,"country":55,"countryCode":56,"cosmosGeoPoint":188,"geoPoint":192,"contacts":193},"Dallas","Texas","75039",{"type":58,"coordinates":189},[190,191],-96.80667,32.78306,{"lat":191,"lon":190},[194],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":196,"state":186,"zip":197,"country":55,"countryCode":56,"cosmosGeoPoint":198,"geoPoint":202,"contacts":203},"Houston","77054",{"type":58,"coordinates":199},[200,201],-95.36327,29.76328,{"lat":201,"lon":200},[204],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":206,"state":186,"zip":207,"country":55,"countryCode":56,"cosmosGeoPoint":208,"geoPoint":212,"contacts":213},"San Antonio","78229",{"type":58,"coordinates":209},[210,211],-98.49363,29.42412,{"lat":211,"lon":210},[214],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":216,"state":217,"zip":218,"country":55,"countryCode":56,"cosmosGeoPoint":219,"geoPoint":223,"contacts":224},"West Valley City","Utah","84119",{"type":58,"coordinates":220},[221,222],-112.00105,40.69161,{"lat":222,"lon":221},[225],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":227,"state":228,"zip":229,"country":55,"countryCode":56,"cosmosGeoPoint":230,"geoPoint":234,"contacts":235},"Fairfax","Virginia","22031",{"type":58,"coordinates":231},[232,233],-77.30637,38.84622,{"lat":233,"lon":232},[236],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"facility":50,"status":51,"city":238,"state":239,"zip":240,"country":55,"countryCode":56,"cosmosGeoPoint":241,"geoPoint":245,"contacts":246},"Seattle","Washington","98109",{"type":58,"coordinates":242},[243,244],-122.33207,47.60621,{"lat":244,"lon":243},[247],{"name":65,"role":45,"phone":34,"phoneExt":34,"email":34},{"type":249,"investigatorFullName":34,"investigatorTitle":34,"investigatorAffiliation":34,"oldNameTitle":34,"oldOrganization":34},"SPONSOR","100595891","phase-1-aventine-1-study-of-avzo-1418-as-a-single-agent-and-in-combination-therapy-in-patients-with-locally-advanced-or-metastatic-solid-tumors-avzo-1418-1001-100595891",false,"NCT07038343","AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)","A Phase 1\u002F2, First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors","Key Inclusion Criteria\n\n* Patient must be an adult, between 18 and 75 years of age with an Eastern Cooperative Oncology Group (ECOG) Performance Status of ≤ 1 and a life expectancy of \\> 3 months.\n* Patients with histologically or cytologically confirmed locally advanced\u002Fmetastatic malignancies for tumor types of preferred indications:\n\n  o Locally advanced or metastatic epithelial solid tumors (as specified in the protocol).\n* Measurable disease as assessed by Investigator using RECIST v1.1.\n* Agree to provide molecular test report results to confirm eligibility and archival tumor samples and\u002For fresh biopsy, as applicable.\n* Other protocol-defined Inclusion criteria apply.\n\nKey Exclusion Criteria\n\n* Uncontrolled hypertension.\n* Patients with active central nervous system (CNS) metastases are not eligible. Patients with asymptomatic and treated brain metastases may participate if they are radiologically stable for at least 4 weeks prior to the first dose of this study and do not require steroid treatment. Patients with suspected or confirmed leptomeningeal disease are not eligible, even if treated.\n* History of drug-induced interstitial lung disease (ILD).\n* History of any serious cardiovascular condition.\n* Infection requiring IV antibiotics, antivirals, or antifungals within 2 weeks prior to first dose.\n* History of a solid organ transplant.\n* Other protocol-defined Exclusion criteria apply.","ALL","18 Years","75 Years",{"count":261,"type":262},480,"ESTIMATED","INTERVENTIONAL",[265,266],"PHASE1","PHASE2","This study, the first clinical trial of AVZO-1418, aims to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, maximum tolerated dose, and antitumor activity of AVZO-1418 when administered intravenously as a monotherapy and potentially in combination therapy to patients with locally advanced or metastatic epithelial solid tumors.",[269,270,271,272,273,274,275,276],"Solid Tumor Cancer","Locally Advanced","Metastatic Solid Tumors","Lung Cancers","Epithelial Tumor","Biliary Tract Cancer (BTC)","Urothelial Cancer","Nasopharyngeal Cancers",[278,279,270,280,281,282,275,283,284,285,286,287,288],"Solid Tumors","Metastatic","Lung Cancer","Epithelial Solid Tumors","Biliary Tract Cancer","SCLC","HER3","EGFR","BTC","Small Cell Lung Cancer","NSCLC","2026-05-11",{"date":291,"type":292},"2026-05-13","ACTUAL",{"date":294,"type":292},"2025-06-04",{"date":296,"type":262},"2030-12",{"name":5,"class":6},18]